Psychemedics Corporation (PMD)
USD 2.67
(0.0%)
USD 2.67
(0.0%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 13.27 Million USD | -29.16% |
| 2022 | 18.73 Million USD | -13.08% |
| 2021 | 21.55 Million USD | -10.21% |
| 2020 | 24 Million USD | -12.81% |
| 2019 | 27.53 Million USD | 10.24% |
| 2018 | 24.97 Million USD | -5.79% |
| 2017 | 26.5 Million USD | 5.9% |
| 2016 | 25.03 Million USD | 11.94% |
| 2015 | 22.36 Million USD | -7.12% |
| 2014 | 24.07 Million USD | 45.49% |
| 2013 | 16.54 Million USD | 17.2% |
| 2012 | 14.12 Million USD | 2.32% |
| 2011 | 13.8 Million USD | 17.29% |
| 2010 | 11.76 Million USD | 10.98% |
| 2009 | 10.6 Million USD | -16.04% |
| 2008 | 12.62 Million USD | -18.85% |
| 2007 | 15.56 Million USD | 17.34% |
| 2006 | 13.26 Million USD | 18.98% |
| 2005 | 11.14 Million USD | 32.15% |
| 2004 | 8.43 Million USD | 16.05% |
| 2003 | 7.26 Million USD | -10.09% |
| 2002 | 8.08 Million USD | -11.26% |
| 2001 | 9.1 Million USD | -17.63% |
| 2000 | 11.05 Million USD | -22.13% |
| 1999 | 14.2 Million USD | -24.06% |
| 1998 | 18.7 Million USD | -1.06% |
| 1997 | 18.9 Million USD | 20.38% |
| 1996 | 15.7 Million USD | 53.92% |
| 1995 | 10.2 Million USD | -0.97% |
| 1994 | 10.3 Million USD | 134.09% |
| 1993 | 4.4 Million USD | 46.67% |
| 1992 | 3 Million USD | -9.09% |
| 1991 | 3.3 Million USD | 120.0% |
| 1990 | 1.5 Million USD | 36.36% |
| 1989 | 1.1 Million USD | 10.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q2 | 10.11 Million USD | -9.32% |
| 2024 Q1 | 11.15 Million USD | -15.96% |
| 2023 Q1 | 17.9 Million USD | -4.4% |
| 2023 FY | 13.27 Million USD | -29.16% |
| 2023 Q4 | 13.27 Million USD | -5.91% |
| 2023 Q3 | 14.1 Million USD | -13.93% |
| 2023 Q2 | 16.38 Million USD | -8.49% |
| 2022 Q4 | 18.73 Million USD | -8.53% |
| 2022 Q2 | 20.45 Million USD | -2.47% |
| 2022 Q1 | 20.96 Million USD | -2.71% |
| 2022 FY | 18.73 Million USD | -13.08% |
| 2022 Q3 | 20.47 Million USD | 0.14% |
| 2021 Q4 | 21.55 Million USD | -8.81% |
| 2021 Q2 | 24.58 Million USD | 0.85% |
| 2021 FY | 21.55 Million USD | -10.21% |
| 2021 Q1 | 24.38 Million USD | 1.57% |
| 2021 Q3 | 23.63 Million USD | -3.88% |
| 2020 Q1 | 25.21 Million USD | -8.43% |
| 2020 Q4 | 24 Million USD | 0.1% |
| 2020 FY | 24 Million USD | -12.81% |
| 2020 Q2 | 25.77 Million USD | 2.25% |
| 2020 Q3 | 23.98 Million USD | -6.97% |
| 2019 Q3 | 26.78 Million USD | 6.56% |
| 2019 Q1 | 25.52 Million USD | 2.22% |
| 2019 FY | 27.53 Million USD | 10.24% |
| 2019 Q4 | 27.53 Million USD | 2.79% |
| 2019 Q2 | 25.13 Million USD | -1.54% |
| 2018 Q2 | 26.42 Million USD | -4.7% |
| 2018 Q1 | 27.72 Million USD | 4.61% |
| 2018 FY | 24.97 Million USD | -5.79% |
| 2018 Q3 | 26.98 Million USD | 2.12% |
| 2018 Q4 | 24.97 Million USD | -7.46% |
| 2017 Q1 | 25.69 Million USD | 2.65% |
| 2017 Q3 | 25.45 Million USD | 7.72% |
| 2017 Q4 | 26.5 Million USD | 4.15% |
| 2017 FY | 26.5 Million USD | 5.9% |
| 2017 Q2 | 23.62 Million USD | -8.04% |
| 2016 Q4 | 25.03 Million USD | -3.46% |
| 2016 Q1 | 22.36 Million USD | 0.01% |
| 2016 Q3 | 25.92 Million USD | 10.13% |
| 2016 FY | 25.03 Million USD | 11.94% |
| 2016 Q2 | 23.54 Million USD | 5.26% |
| 2015 FY | 22.36 Million USD | -7.12% |
| 2015 Q3 | 23.32 Million USD | 2.42% |
| 2015 Q4 | 22.36 Million USD | -4.14% |
| 2015 Q2 | 22.77 Million USD | -0.62% |
| 2015 Q1 | 22.91 Million USD | -4.81% |
| 2014 Q1 | 18.02 Million USD | 8.91% |
| 2014 Q4 | 24.07 Million USD | 2.78% |
| 2014 Q3 | 23.42 Million USD | 3.2% |
| 2014 Q2 | 22.7 Million USD | 25.95% |
| 2014 FY | 24.07 Million USD | 45.49% |
| 2013 Q1 | 13.7 Million USD | -2.92% |
| 2013 Q3 | 15.06 Million USD | 6.62% |
| 2013 Q4 | 16.54 Million USD | 9.86% |
| 2013 FY | 16.54 Million USD | 17.2% |
| 2013 Q2 | 14.12 Million USD | 3.07% |
| 2012 FY | 14.12 Million USD | 2.32% |
| 2012 Q1 | 13.01 Million USD | -5.69% |
| 2012 Q4 | 14.12 Million USD | -1.61% |
| 2012 Q2 | 14.12 Million USD | 8.5% |
| 2012 Q3 | 14.35 Million USD | 1.63% |
| 2011 Q2 | 12.47 Million USD | 5.58% |
| 2011 Q1 | 11.81 Million USD | 0.42% |
| 2011 FY | 13.8 Million USD | 17.29% |
| 2011 Q3 | 12.84 Million USD | 2.98% |
| 2011 Q4 | 13.8 Million USD | 7.43% |
| 2010 FY | 11.76 Million USD | 10.98% |
| 2010 Q3 | 11.42 Million USD | 3.25% |
| 2010 Q4 | 11.76 Million USD | 3.02% |
| 2010 Q2 | 11.06 Million USD | 4.97% |
| 2010 Q1 | 10.53 Million USD | -0.6% |
| 2009 Q2 | 10.32 Million USD | -7.17% |
| 2009 Q4 | 10.6 Million USD | 0.48% |
| 2009 Q1 | 11.12 Million USD | -11.89% |
| 2009 FY | 10.6 Million USD | -16.04% |
| 2009 Q3 | 10.55 Million USD | 2.17% |
| 2008 FY | 12.62 Million USD | -18.85% |
| 2008 Q4 | 12.62 Million USD | -19.59% |
| 2008 Q2 | 15.84 Million USD | 3.34% |
| 2008 Q1 | 15.33 Million USD | -1.48% |
| 2008 Q3 | 15.7 Million USD | -0.87% |
| 2007 Q3 | 15.36 Million USD | 4.97% |
| 2007 Q2 | 14.63 Million USD | 7.71% |
| 2007 Q1 | 13.58 Million USD | 2.46% |
| 2007 FY | 15.56 Million USD | 17.34% |
| 2007 Q4 | 15.56 Million USD | 1.29% |
| 2006 Q2 | 12.08 Million USD | 10.7% |
| 2006 FY | 13.26 Million USD | 18.98% |
| 2006 Q4 | 13.26 Million USD | 2.3% |
| 2006 Q3 | 12.96 Million USD | 7.31% |
| 2006 Q1 | 10.91 Million USD | -2.09% |
| 2005 FY | 11.14 Million USD | 32.15% |
| 2005 Q2 | 10.1 Million USD | 4.01% |
| 2005 Q1 | 9.71 Million USD | 15.24% |
| 2005 Q4 | 11.14 Million USD | 4.03% |
| 2005 Q3 | 10.71 Million USD | 5.99% |
| 2004 Q3 | 8.71 Million USD | 11.73% |
| 2004 Q2 | 7.79 Million USD | 4.43% |
| 2004 Q1 | 7.46 Million USD | 2.75% |
| 2004 FY | 8.43 Million USD | 16.05% |
| 2004 Q4 | 8.43 Million USD | -3.2% |
| 2003 FY | 7.26 Million USD | -10.09% |
| 2003 Q2 | 8.15 Million USD | 2.49% |
| 2003 Q3 | 7.68 Million USD | -5.73% |
| 2003 Q4 | 7.26 Million USD | -5.5% |
| 2003 Q1 | 7.95 Million USD | -1.53% |
| 2002 FY | 8.08 Million USD | -11.26% |
| 2002 Q1 | 8.78 Million USD | -3.53% |
| 2002 Q2 | 9.76 Million USD | 11.09% |
| 2002 Q3 | 9.39 Million USD | -3.71% |
| 2002 Q4 | 8.08 Million USD | -14.0% |
| 2001 Q1 | 10.03 Million USD | -9.28% |
| 2001 Q2 | 10.58 Million USD | 5.55% |
| 2001 Q3 | 9.9 Million USD | -6.41% |
| 2001 FY | 9.1 Million USD | -17.63% |
| 2001 Q4 | 9.1 Million USD | -8.09% |
| 2000 FY | 11.05 Million USD | -22.13% |
| 2000 Q4 | 11.05 Million USD | -9.16% |
| 2000 Q3 | 12.17 Million USD | -6.84% |
| 2000 Q1 | 13.01 Million USD | -8.33% |
| 2000 Q2 | 13.06 Million USD | 0.38% |
| 1999 FY | 14.2 Million USD | -24.06% |
| 1999 Q1 | 17.8 Million USD | -4.81% |
| 1999 Q2 | 17.7 Million USD | -0.56% |
| 1999 Q4 | 14.2 Million USD | -10.13% |
| 1999 Q3 | 15.8 Million USD | -10.73% |
| 1998 Q1 | 20.2 Million USD | 6.88% |
| 1998 FY | 18.7 Million USD | -1.06% |
| 1998 Q4 | 18.7 Million USD | -4.59% |
| 1998 Q3 | 19.6 Million USD | -1.01% |
| 1998 Q2 | 19.8 Million USD | -1.98% |
| 1997 Q2 | 18 Million USD | 8.43% |
| 1997 Q3 | 18.4 Million USD | 2.22% |
| 1997 FY | 18.9 Million USD | 20.38% |
| 1997 Q1 | 16.6 Million USD | 5.73% |
| 1997 Q4 | 18.9 Million USD | 2.72% |
| 1996 Q1 | 12.5 Million USD | 22.55% |
| 1996 Q2 | 13.6 Million USD | 8.8% |
| 1996 FY | 15.7 Million USD | 53.92% |
| 1996 Q4 | 15.7 Million USD | 8.28% |
| 1996 Q3 | 14.5 Million USD | 6.62% |
| 1995 Q2 | 11 Million USD | 4.76% |
| 1995 FY | 10.2 Million USD | -0.97% |
| 1995 Q3 | 11.1 Million USD | 0.91% |
| 1995 Q4 | 10.2 Million USD | -8.11% |
| 1995 Q1 | 10.5 Million USD | 1.94% |
| 1994 Q3 | 9.6 Million USD | 7.87% |
| 1994 Q1 | 4.7 Million USD | 6.82% |
| 1994 FY | 10.3 Million USD | 134.09% |
| 1994 Q2 | 8.9 Million USD | 89.36% |
| 1994 Q4 | 10.3 Million USD | 7.29% |
| 1993 Q1 | 3.4 Million USD | 13.33% |
| 1993 Q2 | 3.7 Million USD | 8.82% |
| 1993 Q3 | 3.8 Million USD | 2.7% |
| 1993 Q4 | 4.4 Million USD | 15.79% |
| 1993 FY | 4.4 Million USD | 46.67% |
| 1992 FY | 3 Million USD | -9.09% |
| 1992 Q1 | 3.2 Million USD | -3.03% |
| 1992 Q4 | 3 Million USD | 0.0% |
| 1991 Q4 | 3.3 Million USD | 0.0% |
| 1991 Q1 | 2.4 Million USD | 60.0% |
| 1991 FY | 3.3 Million USD | 120.0% |
| 1990 Q4 | 1.5 Million USD | 0.0% |
| 1990 FY | 1.5 Million USD | 36.36% |
| 1989 Q2 | 1.8 Million USD | 0.0% |
| 1989 FY | 1.1 Million USD | 10.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Aclaris Therapeutics, Inc. | 197.4 Million USD | 93.278% |
| Applied DNA Sciences, Inc. | 13.65 Million USD | 2.795% |
| Aspira Women's Health Inc. | 6.26 Million USD | -111.913% |
| Biodesix, Inc. | 99.09 Million USD | 86.609% |
| BioNexus Gene Lab Corp. | 11.39 Million USD | -16.406% |
| bioAffinity Technologies, Inc. | 8.22 Million USD | -61.405% |
| bioAffinity Technologies, Inc. | 8.22 Million USD | -61.405% |
| Bionano Genomics, Inc. | 214.4 Million USD | 93.811% |
| CareDx, Inc | 484.61 Million USD | 97.262% |
| Check-Cap Ltd. | 25.01 Million USD | 46.956% |
| Castle Biosciences, Inc. | 477.81 Million USD | 97.223% |
| DarioHealth Corp. | 96.38 Million USD | 86.233% |
| Exact Sciences Corporation | 6.47 Billion USD | 99.795% |
| Fulgent Genetics, Inc. | 1.27 Billion USD | 98.958% |
| Guardant Health, Inc. | 1.78 Billion USD | 99.257% |
| ICON Public Limited Company | 16.98 Billion USD | 99.922% |
| IDEXX Laboratories, Inc. | 3.25 Billion USD | 99.593% |
| Illumina, Inc. | 10.11 Billion USD | 99.869% |
| Intelligent Bio Solutions Inc. | 13.77 Million USD | 3.693% |
| iSpecimen Inc. | 15.81 Million USD | 16.114% |
| Standard BioTools Inc. | 323.06 Million USD | 95.892% |
| MDxHealth SA | 129.13 Million USD | 89.724% |
| 23andMe Holding Co. | 395.16 Million USD | 96.642% |
| Medpace Holdings, Inc. | 1.65 Billion USD | 99.199% |
| Myriad Genetics, Inc. | 1.19 Billion USD | 98.893% |
| Mainz Biomed B.V. | 15.4 Million USD | 13.882% |
| ENDRA Life Sciences Inc. | 6.75 Million USD | -96.472% |
| NeoGenomics, Inc. | 1.68 Billion USD | 99.211% |
| Neogen Corporation | 4.58 Billion USD | 99.711% |
| Inotiv, Inc. | 856.53 Million USD | 98.451% |
| Natera, Inc. | 1.45 Billion USD | 99.089% |
| OpGen, Inc. | 1.88 Million USD | -604.998% |
| OPKO Health, Inc. | 2.01 Billion USD | 99.34% |
| Prenetics Global Limited | 254.17 Million USD | 94.779% |
| Prenetics Global Limited | 254.17 Million USD | 94.779% |
| Precipio, Inc. | 18.1 Million USD | 26.689% |
| Personalis, Inc. | 225.09 Million USD | 94.105% |
| RadNet, Inc. | 2.88 Billion USD | 99.54% |
| Sera Prognostics, Inc. | 95.44 Million USD | 86.096% |
| Sotera Health Company | 3.13 Billion USD | 99.576% |
| Neuronetics, Inc. | 115.83 Million USD | 88.544% |
| Star Equity Holdings, Inc. | 86.97 Million USD | 84.743% |
| Star Equity Holdings, Inc. | 86.97 Million USD | 84.743% |
| Trinity Biotech plc | 59.43 Million USD | 77.673% |
| T2 Biosystems, Inc. | 34.79 Million USD | 61.865% |
| Twist Bioscience Corporation | 776.4 Million USD | 98.291% |
| Exagen Inc. | 56.94 Million USD | 76.696% |